B cell-intrinsic IDO1 regulates humoral immunity to T cell-independent antigens

Journal of Immunology

Volumn 195, Issue 5, 2015, Pages 2374-2382

  Shinde, Rahul ^a   Shimoda, Michiko ^a,b   Chaudhary, Kapil ^a   Liu, Haiyun ^a   Mohamed, Eslam ^a   Bradley, Jillian ^a   Kandala, Sridhar ^a   Li, Xia ^a   Liu, Kebin ^a   McGaha, Tracy L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; IDO1 PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TRYPTOPHANASE; UNCLASSIFIED DRUG; IDO1 PROTEIN, MOUSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDOLEAMINE 2,3 DIOXYGENASE; LYMPHOCYTE ANTIGEN RECEPTOR; THYMUS INDEPENDENT ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME DEGRADATION; FEMALE; HUMORAL IMMUNITY; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; WILD TYPE; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODY FORMATION; ANTIGENS, T-INDEPENDENT; APOPTOSIS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-10; INTERLEUKIN-6; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; RECEPTORS, ANTIGEN, B-CELL;

EID: 84940121515     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402854     Document Type: Article

References (44)

1. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
2. Cerutti, A., M. Cols, and I. Puga. 2013. Marginal zone B cells: virtues of innatelike antibody-producing lymphocytes. Nat. Rev. Immunol. 13: 118-132.
3. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173: 1165-1175.
4. Liu, Y. J., G. D. Johnson, J. Gordon, and I. C. MacLennan. 1992. Germinal centres in T-cell-dependent antibody responses. Immunol. Today 13: 17-21.
5. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J. Exp. Med. 142: 473-482.
6. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
7. Bohnhorst, J., T. Rasmussen, S. H. Moen, M. Fløttum, L. Knudsen, M. Børset, T. Espevik, and A. Sundan. 2006. Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia 20: 1138-1144.
8. MacLennan, I. C., K. M. Toellner, A. F. Cunningham, K. Serre, D. M. Sze, E. Zúñiga, M. C. Cook, and C. G. Vinuesa. 2003. Extrafollicular antibody responses. Immunol. Rev. 194: 8-18.
9. Nikbakht, N., S. Shen, and T. Manser. 2013. Cutting edge: macrophages are required for localization of antigen-activated B cells to the follicular perimeter and the subsequent germinal center response. J. Immunol. 190: 4923-4927.
10. Puga, I., M. Cols, C. M. Barra, B. He, L. Cassis, M. Gentile, L. Comerma, A. Chorny, M. Shan, W. Xu, et al. 2012. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13: 170-180.
11. Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
12. Shapiro-Shelef, M., and K. Calame. 2005. Regulation of plasma-cell development. Nat. Rev. Immunol. 5: 230-242.
13. Arnon, T. I., R. M. Horton, I. L. Grigorova, and J. G. Cyster. 2013. Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature 493: 684-688.
14. Obukhanych, T. V., and M. C. Nussenzweig. 2006. T-independent type II immune responses generate memory B cells. J. Exp. Med. 203: 305-310.
15. Enzler, T., G. Bonizzi, G. J. Silverman, D. C. Otero, G. F. Widhopf, A. Anzelon-Mills, R. C. Rickert, and M. Karin. 2006. Alternative and classical NF-κB signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25: 403-415.
16. Guinamard, R., M. Okigaki, J. Schlessinger, and J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1: 31-36.
17. Kishi, Y., T. Higuchi, S. Phoon, Y. Sakamaki, K. Kamiya, G. Riemekasten, K. Akiyoshi, M. G. Weigert, and T. Tsubata. 2012. Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells. Proc. Natl. Acad. Sci. USA 109: 7811-7816.
18. Zhou, Z., H Niu, Y. Y. Zheng, and L. Morel. 2011. Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice. BMC Immunol. 12: 7.
19. Mauri, C., and A. Bosma. 2012. Immune regulatory function of B cells. Annu. Rev. Immunol. 30: 221-241.
20. Munn, D. H., M. D. Sharma, D. Y. Hou, B. Baban, J. R. Lee, S. J. Antonia, J. L. Messina, P. Chandler, P. A. Koni, and A. L. Mellor. 2004. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114: 280-290.
21. Ravishankar, B., H. Liu, R. Shinde, P. Chandler, B. Baban, M. Tanaka, D. H. Munn, A. L. Mellor, M. C. Karlsson, and T. L. McGaha. 2012. Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. Proc. Natl. Acad. Sci. USA 109: 3909-3914.
22. Metz, R., J. B. Duhadaway, U. Kamasani, L. Laury-Kleintop, A. J. Muller, and G. C. Prendergast. 2007. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67: 7082-7087.
23. Metz, R., C. Smith, J. B. DuHadaway, P. Chandler, B. Baban, L. M. Merlo, E. Pigott, M. P. Keough, S. Rust, A. L. Mellor, et al. 2014. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int. Immunol. 26: 357-367.
24. McGaha, T. L., L. Huang, H. Lemos, R. Metz, M. Mautino, G. C. Prendergast, and A. L. Mellor. 2012. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol. Rev. 249: 135-157.
25. Robinson, C. M., K. A. Shirey, and J. M. Carlin. 2003. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-γ and tumor necrosis factor-α. J. Interferon Cytokine Res. 23: 413-421.
26. Munn, D. H., M. D. Sharma, B. Baban, H. P. Harding, Y. Zhang, D. Ron, and A. L. Mellor. 2005. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22: 633-642.
27. Mezrich, J. D., J. H. Fechner, X. Zhang, B. P. Johnson, W. J. Burlingham, and C. A. Bradfield. 2010. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185: 3190-3198.
28. Liu, H., L. Huang, J. Bradley, K. Liu, K. Bardhan, D. Ron, A. L. Mellor, D. H. Munn, and T. L. McGaha. 2014. GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathology. Mol. Cell. Biol. 34: 428-438.
29. Ravishankar, B., R. Shinde, H. Liu, K. Chaudhary, J. Bradley, H. P. Lemos, P. Chandler, M. Tanaka, D. H. Munn, A. L. Mellor, and T. L. McGaha. 2014. Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proc. Natl. Acad. Sci. USA 111: 4215-4220.
30. Vinuesa, C. G., D. M. Sze, M. C. Cook, K. M. Toellner, G. G. Klaus, J. Ball, and I. C. MacLennan. 2003. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens. Eur. J. Immunol. 33: 297-305.
31. Swanson, C. L., T. J. Wilson, P. Strauch, M. Colonna, R. Pelanda, and R. M. Torres. 2010. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J. Exp. Med. 207: 1485-1500.
32. García de Vinuesa, C., P. O'Leary, D. M. Sze, K. M. Toellner, and I. C. MacLennan. 1999. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur. J. Immunol. 29: 1314-1323.
33. Kucharczak, J., M. J. Simmons, Y. Fan, and C. Gélinas. 2003. To be, or not to be: NF-κB is the answer-role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22: 8961-8982.
34. Chittenden, T., E. A. Harrington, R. O'Connor, C. Flemington, R. J. Lutz, G. I. Evan, and B. C. Guild. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736.
35. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9: 847-856.
36. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
37. Godin-Ethier, J., L. A. Hanafi, J. B. Duvignaud, D. Leclerc, and R. Lapointe. 2011. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive. Mol. Immunol. 49: 253-259.
38. Rodriguez, P. C., D. G. Quiceno, and A. C. Ochoa. 2007. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109: 1568-1573.
39. Jiang, H. Y., and R. C. Wek. 2005. Phosphorylation of the a-subunit of the eukaryotic initiation factor-2 (eIF2α) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280: 14189-14202.
40. Bessede, A., M. Gargaro, M. T. Pallotta, D. Matino, G. Servillo, C. Brunacci, S. Bicciato, E. M. Mazza, A. Macchiarulo, C. Vacca, et al. 2014. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511: 184-190.
41. Pigott, E., and L. Mandik-Nayak. 2012. Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice. Arthritis Rheum. 64: 2169-2178.
42. Merlo, L. M., E. Pigott, J. B. DuHadaway, S. Grabler, R. Metz, G. C. Prendergast, and L. Mandik-Nayak. 2014. IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J. Immunol. 192: 2082-2090.
43. Scott, G. N., J. DuHadaway, E. Pigott, N. Ridge, G. C. Prendergast, A. J. Muller, and L. Mandik-Nayak. 2009. The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity. J. Immunol. 182: 7509-7517.
44. Eleftheriadis, T., T. Sparopoulou, G. Antoniadi, V. Liakopoulos, I. Stefanidis, and G. Galaktidou. 2011. Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration. Daru 19: 236-239.